Literature DB >> 19353726

Nigrostriatal upregulation of 5-HT2A receptors correlates with motor dysfunction in progressive supranuclear palsy.

Maria Stamelou1, Andreas Matusch, David Elmenhorst, René Hurlemann, Karla M Eggert, Karl Zilles, Wolfgang H Oertel, Günter U Höglinger, Andreas Bauer.   

Abstract

A dysfunction of multiple neurotransmitter systems is assumed as a neurochemical basis of the akinetic-rigid syndrome of progressive supranuclear palsy (PSP). In vitro studies have produced conflicting results on the serotoninergic system in PSP. We, therefore, studied the binding potential of the serotonin 2A (5-HT(2A)) receptor ligand [18F]altanserin in 8 patients with clinically probable PSP and 13 healthy controls using positron emission tomography. We found an up-regulation of 5-HT(2A) receptors in the substantia nigra and, to a lower degree, in the striatum, while neocortical 5- HT(2A) receptor densities showed no changes upon partial-volume correction. Nigral and striatal receptor changes were significantly correlated with patients' scores of motor dysfunction (UPDRS III, PSP-rating scale) pointing to a functional relevance of the described findings. (c) 2009 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19353726     DOI: 10.1002/mds.22533

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  6 in total

Review 1.  A Review of Treatment Options for Progressive Supranuclear Palsy.

Authors:  Maria Stamelou; Günter Höglinger
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

Review 2.  Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Authors:  Jennifer L Whitwell; Günter U Höglinger; Angelo Antonini; Yvette Bordelon; Adam L Boxer; Carlo Colosimo; Thilo van Eimeren; Lawrence I Golbe; Jan Kassubek; Carolin Kurz; Irene Litvan; Alexander Pantelyat; Gil Rabinovici; Gesine Respondek; Axel Rominger; James B Rowe; Maria Stamelou; Keith A Josephs
Journal:  Mov Disord       Date:  2017-05-13       Impact factor: 10.338

Review 3.  Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders.

Authors:  Sonja W Scholz; Jose Bras
Journal:  Int J Mol Sci       Date:  2015-10-16       Impact factor: 5.923

4.  Multireceptor fingerprints in progressive supranuclear palsy.

Authors:  Wang Zheng Chiu; Laura Donker Kaat; Agnita J W Boon; Wouter Kamphorst; Axel Schleicher; Karl Zilles; John C van Swieten; Nicola Palomero-Gallagher
Journal:  Alzheimers Res Ther       Date:  2017-04-17       Impact factor: 6.982

5.  Alteration of the Dopamine Receptors' Expression in the Cerebellum of the Lysosomal Acid Phosphatase 2 Mutant (Naked-Ataxia (NAX)) Mouse.

Authors:  Mehdi Mehdizadeh; Niloufar Ashtari; Xiaodan Jiao; Maryam Rahimi Balaei; Asghar Marzban; Farshid Qiyami-Hour; Jiming Kong; Saeid Ghavami; Hassan Marzban
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

Review 6.  Neurotransmitter deficits from frontotemporal lobar degeneration.

Authors:  Alexander G Murley; James B Rowe
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.